While the PSP cases (FTLD-Tau – FTLD3m) had two hypermethylated CpGs (cg02804087 and cg11489262) in the 5’UTR region of the gene, none of which surpassed the chosen thresholds or same direction of effect in any other FTLD subtype. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.